CD38 and B-cell chronic lymphocytic leukemia: Since CD38 and ZAP70 are important prognostic markers of CLL, we divided patients into the following groups (using a 20 % cutoff value for CD38 and ZAP70): CD38+ and CD38−, and ZAP70+ and ZAP70−.